As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: June 21, 2012
by Medical XPress:
Australian researchers have found biomarkers in the blood that could help develop a test to identify people in the early stages of Alzheimer’s disease.
University of New South Wales School of Psychiatry Professor Perminder Sachdev and his team looked at apolipoproteins, which transport cholesterol in the blood, and found they were dysregulated – or abnormal – in patients with mild cognitive impairment. The research findings are published in the journal PLOS ONE.
“Essentially, this is one step towards developing a suite of biomarkers to include a number of different proteins that will identify individuals with mild cognitive impairment who will probably go on to develop Alzheimer’s disease or dementia in the future,” Professor Sachdev says.
Evidence suggests these proteins are involved in Alzheimer’s disease and some other brain diseases, Professor Sachdev says.
The researchers examined the group of apolipoproteins in the blood of more than 1,000 study participants over a two-year period. About half of the group also had Magnetic Resonance Imaging brain scans and were rated according to their cognitive impairment.
“Apolipoproteins have been of interest in Alzheimer’s disease for a number of reasons,” Professor Sachdev says.
“It is know that one variant of the gene for one type of apolipoprotein, Apo E, increases the risk of Alzheimer’s. Another of these proteins, Apo J or clusterin, has been found in the brain lesions of people with Alzheimer’s.
“We found abnormal levels of clusterin but also some other apolipoproteins in the blood of older individuals with memory problems, and these levels tended to predict who showed worsening of their mental functions over two years.”
As early indicators of cognitive decline, these apolipoproteins may also become targets of treatment or preventative healthcare measures, the authors say.
The number of older people, including those living with dementia, is rising, as younger age mortality declines. However, the age-specific incidence of dementia has fallen in many countries, probably because of improvements in education, nutrition, health...
Among HIV-negative people, studies have found that loneliness can interfere with mental health, cognitive functioning and quality of life. In this population, one analysis has found that persistent loneliness is associated with a...
Researchers believe game-changing test will be available to doctors in two years. A simple blood test may be able to tell you whether you have Alzheimer’s disease and, in some cases, it can detect the...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.